U.S. Markets open in 6 hrs 22 mins

Hedge Funds Have Never Been This Bullish On Zomedica Pharmaceuticals Corp. (ZOM)

Debasis Saha

Is Zomedica Pharmaceuticals Corp. (NYSE:ZOM) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. The top picks of these firms have historically outperformed the market when we account for known risk factors, making them very valuable investment ideas.

Is Zomedica Pharmaceuticals Corp. (NYSE:ZOM) a cheap stock to buy now? Money managers are in an optimistic mood. The number of long hedge fund positions rose by 3 in recent months. Our calculations also showed that ZOM isn't among the 30 most popular stocks among hedge funds (click for Q3 rankings and see the video below for Q2 rankings). Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

5 Most Popular Stocks Among Hedge Funds

In today’s marketplace there are a multitude of methods shareholders put to use to size up their stock investments. A pair of the most innovative methods are hedge fund and insider trading sentiment. Our researchers have shown that, historically, those who follow the best picks of the top investment managers can trounce their index-focused peers by a healthy margin (see the details here).

[caption id="attachment_258236" align="alignnone" width="600"] Ken Griffin of Citadel Investment Group[/caption]

Ken Griffin

We leave no stone unturned when looking for the next great investment idea. For example Discover is offering this insane cashback card, so we look into shorting the stock. One of the most bullish analysts in America just put his money where his mouth is. He says, "I'm investing more today than I did back in early 2009." So we check out his pitch. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. We even check out this option genius' weekly trade ideas. This December, we recommended Adams Energy as a one-way bet based on an under-the-radar fund manager's investor letter and the stock already gained 20 percent. Keeping this in mind let's take a look at the recent hedge fund action encompassing Zomedica Pharmaceuticals Corp. (NYSE:ZOM).

How have hedgies been trading Zomedica Pharmaceuticals Corp. (NYSE:ZOM)?

At Q3's end, a total of 5 of the hedge funds tracked by Insider Monkey were long this stock, a change of 150% from one quarter earlier. The graph below displays the number of hedge funds with bullish position in ZOM over the last 17 quarters. With the smart money's sentiment swirling, there exists a few notable hedge fund managers who were upping their holdings meaningfully (or already accumulated large positions).

Is ZOM A Good Stock To Buy?

More specifically, LMR Partners was the largest shareholder of Zomedica Pharmaceuticals Corp. (NYSE:ZOM), with a stake worth $0 million reported as of the end of September. Trailing LMR Partners was Citadel Investment Group, which amassed a stake valued at $0 million. Renaissance Technologies, Millennium Management, and Paloma Partners were also very fond of the stock, becoming one of the largest hedge fund holders of the company. In terms of the portfolio weights assigned to each position LMR Partners allocated the biggest weight to Zomedica Pharmaceuticals Corp. (NYSE:ZOM), around 0.0009% of its 13F portfolio. Paloma Partners is also relatively very bullish on the stock, earmarking 0.0001 percent of its 13F equity portfolio to ZOM.

Consequently, key hedge funds have been driving this bullishness. Citadel Investment Group, managed by Ken Griffin, established the largest position in Zomedica Pharmaceuticals Corp. (NYSE:ZOM). Citadel Investment Group had $0 million invested in the company at the end of the quarter. Renaissance Technologies also made a $0 million investment in the stock during the quarter.

Let's now take a look at hedge fund activity in other stocks similar to Zomedica Pharmaceuticals Corp. (NYSE:ZOM). We will take a look at Alimera Sciences Inc (NASDAQ:ALIM), Quorum Health Corporation (NYSE:QHC), Nautilus, Inc. (NYSE:NLS), and RCM Technologies, Inc. (NASDAQ:RCMT). All of these stocks' market caps are similar to ZOM's market cap.

[table] Ticker, No of HFs with positions, Total Value of HF Positions (x1000), Change in HF Position ALIM,9,13895,0 QHC,11,7125,0 NLS,13,6908,-1 RCMT,3,2784,1 Average,9,7678,0 [/table]

View table here if you experience formatting issues.

As you can see these stocks had an average of 9 hedge funds with bullish positions and the average amount invested in these stocks was $8 million. That figure was $0 million in ZOM's case. Nautilus, Inc. (NYSE:NLS) is the most popular stock in this table. On the other hand RCM Technologies, Inc. (NASDAQ:RCMT) is the least popular one with only 3 bullish hedge fund positions. Zomedica Pharmaceuticals Corp. (NYSE:ZOM) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we'd rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 20 most popular stocks among hedge funds returned 37.4% in 2019 through the end of November and outperformed the S&P 500 ETF (SPY) by 9.9 percentage points. Unfortunately ZOM wasn't nearly as popular as these 20 stocks (hedge fund sentiment was quite bearish); ZOM investors were disappointed as the stock returned -7.8% during the first two months of the fourth quarter and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 20 most popular stocks among hedge funds as 70 percent of these stocks already outperformed the market in Q4.

Disclosure: None. This article was originally published at Insider Monkey.

Related Content

  • CNBC’s Jim Cramer: Here comes the panic, but don’t rush to buy the dip
    Business
    MarketWatch

    CNBC’s Jim Cramer: Here comes the panic, but don’t rush to buy the dip

    That's how CNBC host Jim Cramer described Monday's sharp selloff in the stock market, which is shaping up to be the worst we've seen in several months amid mounting fears of the spread of the coronavirus. So is it time for a little bottom-fishing ahead of a very crowded docket of earnings report in the coming days? We've been saying over and over if we get an exogenous event that's when you get the sell off, that's when you have to buy,” Cramer explained.

  • The main reason for the stock market’s decline is NOT the coronavirus
    Business
    MarketWatch

    The main reason for the stock market’s decline is NOT the coronavirus

    The coronavirus is getting a bum rap as the cause of the stock market's recent weakness. That decline gathered steam on Monday, when the Dow Jones Industrial Average (DJIA) was at one point down more than 500 points. It's not that any of us should have sympathy for the virus, of course.

  • World
    TheStreet.com

    Jim Cramer: 6 Stocks to Buy on Coronavirus Fears

    The selling was so intense in that period that it didn't matter if you were buying Verizon or Caterpillar or American Electric Power . There were so many people who left Wuhan, the epicenter, when they were still healthy and they are now coming down with the illness. It's pretty clear that the virus spreads from rapidly person to person, so rapidly that we are hearing lots of conspiracies about a bio lab in Wuhan that might have mistakenly discharged the coronavirus and it was not transmitted initially by animals to humans.

  • Dow Jones Futures Rise After China Coronavirus Slams Stock Market Rally; Apple, AMD, Starbucks On Tap; Acceleron Skyrockets
    Business
    Investor's Business Daily

    Dow Jones Futures Rise After China Coronavirus Slams Stock Market Rally; Apple, AMD, Starbucks On Tap; Acceleron Skyrockets

    Dow Jones futures rose modestly Monday, along with S&P 500 futures and Nasdaq futures after China coronavirus fears slammed the stock market rally Monday. Acceleron Pharma skyrocketed overnight on blood pressure drug news. Apple, Advanced Micro Devices and Starbucks are key earnings Tuesday.

  • Business
    Barrons.com

    3 Biotech Stocks Are Soaring Because Everyone Wants a Coronavirus Vaccine

    Shares of a handful of small and mid-sized biotechs that are working on vaccines for the Wuhan coronavirus soared on Monday, as worries over the spread of the illness weigh on the broader markets. “Companies stating their interest in development vaccines for coronavirus are likely too late, as we saw similar commentary around SARS and other similar situations,” wrote Jefferies health care trading desk analyst Jared Holz in a note Monday morning. The news reports bumping the three biotech stocks relate to early-stage programs using novel scientific modalities to move quickly on possible vaccines for the disease, which has killed at least 80 people worldwide.

  • The first stock-market ‘correction since October has begun,’ says Morgan Stanley analyst who called 2018 tech rout
    Business
    MarketWatch

    The first stock-market ‘correction since October has begun,’ says Morgan Stanley analyst who called 2018 tech rout

    However, his prediction that the market is more likely to decline by half that much indicates that he's forecasting a retreat from stocks that have hovered near records rather than a traditional correction. Wall Street investors, perhaps, shouldn't need the strategist to determine the current state of the equities, however. On Monday, the Dow Jones Industrial Average Stock markets have traded south in the past several sessions, with the Dow momentarily losing its grip on gains for 2020, as a rapidly spreading virus in China has sparked fears of a global outbreak that could curtail economic expansion in the world's second-largest economy.

  • Apple, AMD earnings: What to know in markets Tuesday
    Business
    Yahoo Finance

    Apple, AMD earnings: What to know in markets Tuesday

    Earnings season shifts into higher gear on Tuesday with a slew of quarterly reports, but investors will be paying especially close attention to tech giant Apple (AAPL) and chipmaker Advanced Micro Devices (AMD). iPhone and wearable sales are likely to help Apple beat consensus expectations, according to RBC analyst Robert Muller. The firm used social media data to assess consumer interest in Apple's products and the results were favorable to the company.

  • Lucky's Market files for bankruptcy, plans to shut down Colorado headquarters
    Business
    American City Business Journals

    Lucky's Market files for bankruptcy, plans to shut down Colorado headquarters

    Lucky's Market has filed for bankruptcy and is closing its corporate headquarters in Niwot. The Lucky's Market Parent Company — a registered LLC — owes about $36 million to its 30 largest creditors, based on Chapter 11 bankruptcy reorganization petitions the company and its affiliated stores filed Monday in the U.S. Bankruptcy Court in Delaware. The company checked the box on the paperwork saying it had between 10,001 and 25,000 creditors.

  • Typical Retirement Savings By Age Groups: Are Yours Bigger?
    Business
    Investor's Business Daily

    Typical Retirement Savings By Age Groups: Are Yours Bigger?

    Active savers — in this case, Americans who own an IRA and-or a 401(k) account in the custody of Fidelity Investments — had savings for retirement of $215,400 as of Sept. according to new data IBD has obtained from Fidelity. In contrast, the average for all working-age families is shockingly low.

  • Fog grounded choppers at time of Bryant crash
    U.S.
    Associated Press Videos

    Fog grounded choppers at time of Bryant crash

    The helicopter carrying Kobe Bryant and eight others that crashed into a hillside outside Los Angeles was flying in foggy conditions considered dangerous enough that local police agencies grounded their choppers. All nine people on board died. Jan.

  • Exxon at a 10-Year Low Shows Challenges for Oil’s Biggest Major
    Business
    Bloomberg

    Exxon at a 10-Year Low Shows Challenges for Oil’s Biggest Major

    Once the gold-standard of Big Oil, the stock closed Monday at its lowest since October 2010, amid a slump in oil prices due to concerns about weak demand coupled with a glut. Chief Executive Officer Darren Woods is running a counter-cyclical strategy by investing heavily in new oil and gas assets, at a time when many investors are demanding energy companies improve returns for shareholders. Exxon is betting on a “windfall of cash” to arrive from its investments sometime in the mid to late 2020s, said Noah Barrett, a Denver-based energy analyst at Janus Henderson, which manages $356 billion.

  • Rare VIX Inversion Points to Potential End of U.S. Equity Rout
    Business
    Bloomberg

    Rare VIX Inversion Points to Potential End of U.S. Equity Rout

    Monday's slump in the S&P 500 has created the rare situation where the term structure for the Cboe Volatility Index is inverted. As the VIX surged to its highest level since October, the spot price exceeded the the March future prices, indicating more perceived risk in the immediate term rather than the longer term. Such an inversion usually doesn't last long and can be a sign that the sell-off may be nearing its end, according to Susquehanna's co-head of derivatives strategy, Chris Murphy.

  • Analysts: 2 Big 8% Dividend Stocks to Buy (And 1 to Sell)
    Business
    TipRanks

    Analysts: 2 Big 8% Dividend Stocks to Buy (And 1 to Sell)

    Dividends provide a steady income stream, whether markets go up or down. With that in mind, we delved into the market data from TipRanks.com to get the lowdown on 3 high-yield dividend stocks, two of which analysts think are set to shine in 2020, and one whose prospects aren't quite as bright. Viper has exploration rights in more than 14,000 acres in the Midland, which are exploited by third parties and subsidiaries who then pay the royalties that make up Viper's income.

  • A-list celebrities attend lavish party at Jeff Bezos' D.C. home
    Politics
    Yahoo Finance Video

    A-list celebrities attend lavish party at Jeff Bezos' D.C. home

    Jeff Bezos threw a lavish party at his new Washington, D.C. home, and some high-profile names were in attendance. These include Federal Reserve chairman Jerome Powell, Ben Stiller, Kellyanne Conway, Bill Gates, and Jared and Ivanka Trump.

  • 3 “Strong Buy” Stocks Under $5 That Are Ready to Run Higher
    Business
    TipRanks

    3 “Strong Buy” Stocks Under $5 That Are Ready to Run Higher

    With Orbcomm's shares trading roughly 4X our 2021 adjusted EBITDA estimate, we view the risk reward on the shares as very positive… We believe if management can execute, the shares should return to higher multiples. What does it mean, then? It means that Walkley keeps his Buy rating on Orbcomm.

  • AMD chief Lisa Su joins Cisco board as networking giant touts 5G, silicon products
    Business
    American City Business Journals

    AMD chief Lisa Su joins Cisco board as networking giant touts 5G, silicon products

    Lisa Su, the CEO and president of chipmaker Advanced Micro Devices Inc., has joined the board of San Jose-based Cisco Systems Inc. Cisco said Monday that Su, who has been CEO at AMD since 2014, joins the board of the networking giant effective immediately. "Lisa is an accomplished business leader with deep expertise in the semiconductor industry," Cisco CEO and Chairman Chuck Robbins said in a statement. "We look forward to her contributions to Cisco's board and our business as we continue to develop ground breaking technologies, and a new internet for the 5G era that will help our customers innovate faster than ever before." At Santa Clara-based AMD, Su has overseen record revenues and new products.

  • Why Warren Buffett's Berkshire Hathaway is a hot stock pick for millennials
    Business
    Yahoo Finance

    Why Warren Buffett's Berkshire Hathaway is a hot stock pick for millennials

    When it comes to investing, it appears 89-year-old Warren Buffett is still hip with millennials.The Oracle of Omaha's Berkshire Hathaway landed on millennials' top 10 list of investments in the fourth quarter of 2019, according to new research from the clearing house Apex Clearing. To be sure, they're buying the less expensive Berkshire Hathaway Class-B stock (BRK-B), which currently trades at around $200 per share, compared to Berkshire's Class-A shares (BRK-A), which have traded at or near $300,000 per share for the last two years. The Apex Q4 Millennial 100 report analyzed more than 734,000 investment accounts owned by U.S.-based investors with an average age of 31.

  • Business
    Benzinga

    8 Cloud Stocks To Own In 2020

    Bank of America has a Buy rating and $215 price target for CRM stock. While Amazon's core e-commerce business is still going strong, its Amazon Web Services cloud segment has been the company's major growth driver in recent years. Analyst Justin Post has said Amazon is the earliest in its penetration curve of all the FANG stocks, and AWS and advertising should generate $4.7 billion in incremental profits for Amazon this year.

  • Liz Weston: Retirees' top money regrets
    Business
    Associated Press

    Liz Weston: Retirees' top money regrets

    In a previous column, I detailed retirees' biggest lifestyle regrets, such as not traveling more before their health gave out and not communicating clearly with a partner about what they hoped retirement would be like. The big ones, of course, are starting to save too late and not saving enough, but there are other common regrets, according to certified financial planners from the Financial Planning Association and the Alliance of Comprehensive Planners. About 1 out of 3 Social Security recipients apply for benefits at the earliest age, which is 62.

  • Stock Market Coughs After Catching Chinese Flu; Time To Take Profits In These 2 Big Names?
    Business
    Investor's Business Daily

    Stock Market Coughs After Catching Chinese Flu; Time To Take Profits In These 2 Big Names?

    The stock market fell sharply early Monday but recovered from the lows in later trading as concerns about the spread of the deadly Chinese coronavirus hit markets around the world. Apple and Tesla, both with deep ties to China and reporting earnings this week, fell. The Nasdaq, a haven for growth stocks, bore the brunt of the flu-related sell-off, declining 1.7%.

  • The stock market’s biggest problem this week isn’t the coronavirus or Mideast tensions, strategist warns
    Business
    MarketWatch

    The stock market’s biggest problem this week isn’t the coronavirus or Mideast tensions, strategist warns

    Hogan said the S&P 500 could see a pullback of as much as 5% — and it won't be because of the coronavirus or rising tensions with Iran. With a crowded slate of earnings on tap, Hogan warned that it will probably be the biggest winners getting the biggest haircuts. “There are five technology names that are driving a good chunk of the movement in the S&P. On the other side, you see the utilities index,” he explained.

  • What the new FICO credit score reveals about the precarious state of Americans’ finances
    Business
    MarketWatch

    What the new FICO credit score reveals about the precarious state of Americans’ finances

    Fair Isaac Corp. (FICO) is changing how it calculates credit scores, and the new criteria reveal some of the trouble spots in Americans' financial health. Two of the most substantial changes in the new scoring models, FICO Score 10 and 10T, are how they account for personal loans and how they measure creditworthiness over time. Previous FICO score models were not anchored as much to personal loan data, yet since 2015 the number of personal loans has risen 42%, making personal loans the fastest-growing category of debt in the country.

  • Which tech stock is best? Here’s how the ‘big five’ companies stack up as they report earnings
    Business
    MarketWatch

    Which tech stock is best? Here’s how the ‘big five’ companies stack up as they report earnings

    Sales and earnings Rather than focus on quarterly “earnings beats,” here are annual sales and earnings-per-share estimates for calendar 2020 and 2019 (since not all have fiscal years that end Dec. 31). Tables in this article are sorted by the companies' market capitalization, with Alphabet's being the sum of the market values for its Class A (GOOGL) and Class C (GOOG) shares. Together, these stocks have a combined market cap of $5.05 trillion, or 18% of the S&P 500 Index (SPX) Earnings per share for Alphabet's Class A and Class C are the same, but Class A shares have voting rights, while Class C shares don't, so the Class A shares trade at a slight premium.

  • Business
    TheStreet.com

    Kass: Apple Is the Most Consequential Investment That Warren Buffett Ever Made

    Berkshire's investment in Apple is a bold manifestation of his avoidance of portfolio diversification which has characterized his investing style for over five decades... it is the largest investment that Berkshire has ever made and, by far, the most profitable (on a time-adjusted or absolute dollar basis) of any investment portfolio position he has made. On an initial investment of $36 billion, Berkshire has made approximately $43 billion.

  • Chip stocks catch brunt of tech decline, but coronavirus could benefit U.S. memory makers
    Business
    MarketWatch

    Chip stocks catch brunt of tech decline, but coronavirus could benefit U.S. memory makers

    Chip-related stocks fell at a faster rate than the broader market Monday as coronavirus fears rattled investors, but analysts contend that the outbreak could have a positive effect for some domestic semiconductor companies. The PHLX Semiconductor Index (SOX) sank 3.9% to close at 1,848.86, for its worst day since Aug. 23, when the index fell 4.4%. From an investment standpoint, the coronavirus and the subsequent quarantining of Wuhan, China, poses a possible benefit to U.S. memory chip companies like Micron Technology Inc. (MU) and Western Digital Corp. (WDC)  Analysts noted that the outbreak will likely upset operations at Wuhan-based Yangtze Memory Technologies Co. and Wuhan Xinxin Semiconductor Manufacturing Corp., Chinese rivals to those memory manufacturers.